What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Opioid
- Analgesic
Michael H. Ossipov mainly focuses on Neuroscience, Neuropathic pain, Hyperalgesia, Anesthesia and Nociception.
His Neuropathic pain research is multidisciplinary, incorporating elements of Nerve impulse, Nerve injury, Sensory system, Dorsal root ganglion and Dynorphin.
His research integrates issues of Endocrinology and Dynorphin A in his study of Dynorphin.
His Hyperalgesia research incorporates themes from Cholecystokinin and Spinal cord.
His study in Nociception is interdisciplinary in nature, drawing from both Morphine, Central nervous system, Analgesic and Opioid.
His Opioid research is multidisciplinary, incorporating perspectives in Noxious stimulus, Pharmacology and Rostral ventromedial medulla.
His most cited work include:
- Chronic pain and medullary descending facilitation (799 citations)
- Potent and nontoxic antisense oligonucleotides containing locked nucleic acids (656 citations)
- Central modulation of pain (628 citations)
What are the main themes of his work throughout his whole career to date?
Michael H. Ossipov mainly investigates Anesthesia, Pharmacology, Neuropathic pain, Nociception and Neuroscience.
His Anesthesia research incorporates elements of Sumatriptan, Rostral ventromedial medulla and Allodynia.
In Pharmacology, Michael H. Ossipov works on issues like Clonidine, which are connected to Alpha-2 adrenergic receptor.
His work in Neuropathic pain addresses issues such as Nerve injury, which are connected to fields such as Spinal nerve and Sciatic nerve.
His studies in Nociception integrate themes in fields like Dynorphin, Endocrinology and Opioid.
His work carried out in the field of Neuroscience brings together such families of science as Glial cell line-derived neurotrophic factor and Nociceptor.
He most often published in these fields:
- Anesthesia (35.71%)
- Pharmacology (35.12%)
- Neuropathic pain (32.14%)
What were the highlights of his more recent work (between 2012-2021)?
- Neuropathic pain (32.14%)
- Anesthesia (35.71%)
- Migraine (9.52%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Neuropathic pain, Anesthesia, Migraine, Pharmacology and Neuroscience.
His studies deal with areas such as Morphine, Nociception, Endogenous opioid, Opioid and Spinal cord as well as Neuropathic pain.
His Endogenous opioid research focuses on Dynorphin and how it connects with Endocrinology and Lumbar Spinal Cord.
Michael H. Ossipov has included themes like Opioid analgesics, Dopaminergic and Nucleus accumbens in his Anesthesia study.
His Pharmacology study combines topics from a wide range of disciplines, such as Chronic pain, κ-opioid receptor and Allodynia.
In his study, Periaqueductal gray is strongly linked to Serotonergic, which falls under the umbrella field of Neuroscience.
Between 2012 and 2021, his most popular works were:
- Descending pain modulation and chronification of pain. (298 citations)
- Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial: (174 citations)
- The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine. (169 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Opioid
His primary areas of investigation include Migraine, Calcitonin gene-related peptide, Anesthesia, Conditioned place preference and Neuropathic pain.
Michael H. Ossipov interconnects Clinical endpoint, Quality of life, Pharmacology and Allodynia in the investigation of issues within Calcitonin gene-related peptide.
His Conditioned place preference study combines topics in areas such as Dopaminergic, Nucleus accumbens and Rostral ventromedial medulla.
His Rostral ventromedial medulla study combines topics from a wide range of disciplines, such as Lidocaine, Nerve injury, Lesion and Spinal cord.
His Neuropathic pain research is included under the broader classification of Neuroscience.
His research integrates issues of Morphine, Hyperalgesia and Opioid in his study of Dopamine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
